CompletedPhase 4

Real-Time Myocardial Perfusion Echocardiography in the ICU

United States24 participantsStarted 2017-09-28

Plain-language summary

This study is being done to find out if and how much the use of RTMPE improves a provider's confidence in the diagnosis they assign. This is important because the use of RTMPE may decrease the need for any additional invasive testing.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adults age ≥ 18 years
✓. Located in a designated ICU
✓. TTE ordered by the primary care team
✓. Significant delta in troponin trend
✓. Concern for myocardial ischemia
✓. Women of child-bearing potential must have a clinical negative pregnancy test result
✓. Experienced sonographer available to complete RTMPE portion of the exam
✓. Provider willing to complete the study survey

Exclusion criteria

✕. Adults \< 18 years
✕. Contraindication to echo contrast administration
✕. Location other than an ICU
✕. No significant delta in troponin trend

What they're measuring

Change from Baseline Diagnostic Confidence Post-Echocardiography

Timeframe: through study completion, anticipated 1 year

Trial details

NCT IDNCT03173716

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-12-31

View on ClinicalTrials.gov More Myocardial Perfusion Imaging trials